Robert Gronke, PhD

Robert Gronke is a Senior Principal Scientist in the Antisense Oligonucleotide department at Biogen. For 34 years, he’s lead the purification process development, CMC leadership, and new technology assessments for Biogen’s commercial ASO products Qalsody and Spinraza along with biological products AVONEX, PLEGRIDY, BENEPALI, plus more than 25 clinical products. Rob currently manages a group of 6 associate scientists.

Prior to joining Biogen, Inc., Dr. Gronke was a post-doctoral fellow in the Pharmacology Department at Merck. He holds a Ph.D. degree in Biochemistry from the University of Kansas, Lawrence Kansas and a BS degree in Biochemistry from Northern Illinois University.